Pharma Sector
Latest news, explainers and analysis on Pharma Sector. Tracking 5 stories on Arth Vani.
Connected in the graph
Latest on Pharma Sector
Beyond Generics: Why Indian Pharma’s Shift to Innovation Offers Long-Term Value
The Indian pharmaceutical sector is moving away from low-margin generic drugs toward high-value innovation and advanced R&D. While the stock market has yet to fully price in this transformation, emerging opportunities in GLP-1 drugs and global supply chain shifts suggest significant growth potential through 2035.
Nifty Eyes 25,500 Recovery: Market Expert Bets on Smallcaps and Pharma
Market veteran Gautam Shah predicts a positive shift for Indian equities, with the Nifty 50 potentially reaching the 25,500 mark. The outlook suggests a pivot towards smallcap stocks, healthcare, and the Adani Group as the broader bull market remains intact.
Dr Reddy’s Shares Dip: What the Downturn Means for Your Pharma Portfolio
Shares of Dr. Reddy's Laboratories faced a decline today, reflecting a broader cooling off in pharmaceutical returns. Retail investors should monitor this Nifty 50 heavyweight as sector-specific volatility impacts both direct holdings and mutual fund NAVs.
Small and Midcap Correction Over: Porinju Veliyath Names Thomas Cook as New Bet
Veteran investor Porinju Veliyath believes the recent downturn in small and midcap stocks has bottomed out, offering a fresh entry point for retail investors. He has recently added Thomas Cook India to his portfolio while highlighting IT and pharma as long-term winners.
Sun Pharma Stock Moves: Assessing India’s Largest Drugmaker Amid Market Fluctuations
Sun Pharmaceutical Industries is seeing active trading as a key Nifty 50 constituent. As India's top drugmaker, its performance remains a crucial indicator for retail investors and those holding pharma-sector mutual funds.
Some listings may be sponsored and Arth Vani may earn a referral fee. All information is for educational purposes only — verify terms and suitability with the provider before acting. Not financial advice.